The 117th meeting of the advisory committee to the NIH director tackles a thorny agenda, from shielding research from undue influences--both domestic and foreign--to ending the MACH trial after discovering improprieties in study design and implementation.
Dr. Freeman Hrabowski III, longtime president of the University of Maryland-Baltimore County, shares his insights on training the next generation of biomedical investigators, regardless of their backgrounds. He calls for a change in culture regarding expectations of students who are underrepresented minorities.
CDC director Dr. Robert Redfield reports that the nation's opioid epidemic bears with it an increased risk of infectious disease, including HIV and hepatitis C. There is, however, "science on the shelf" that can address both threats.
On the Cover
Background-free imaging of magnetically modulated fluorescent nanodiamonds in the lymph node of a mouse.